427 related articles for article (PubMed ID: 10786691)
1. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
2. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
3. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells.
Tanaka T; Rodríguez de la Concepción ML; De Luca LM
Biochem Pharmacol; 2001 Jun; 61(11):1347-55. PubMed ID: 11331070
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
5. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway.
Kopf E; Plassat JL; Vivat V; de Thé H; Chambon P; Rochette-Egly C
J Biol Chem; 2000 Oct; 275(43):33280-8. PubMed ID: 10869350
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of UV irradiation on nuclear retinoid receptor levels in cultured keratinocytes and melanocytes.
Andersson E; Rosdahl I; Törmä H; Vahlquist A
Exp Dermatol; 2003 Oct; 12(5):563-71. PubMed ID: 14705796
[TBL] [Abstract][Full Text] [Related]
8. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
[TBL] [Abstract][Full Text] [Related]
9. Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.
Ye XF; Liu S; Wu Q; Lin XF; Zhang B; Wu JF; Zhang MQ; Su WJ
World J Gastroenterol; 2003 Sep; 9(9):1915-9. PubMed ID: 12970875
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways.
Karlsson T; Vahlquist A; Törmä H
J Dermatol Sci; 2010 Mar; 57(3):207-13. PubMed ID: 20122816
[TBL] [Abstract][Full Text] [Related]
11. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif.
Spencer ML; Theodosiou M; Noonan DJ
J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225
[TBL] [Abstract][Full Text] [Related]
12. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes.
Yamaguchi S; Murata Y; Nagaya T; Hayashi Y; Ohmori S; Nimura Y; Seo H
J Mol Endocrinol; 1999 Feb; 22(1):81-90. PubMed ID: 9924183
[TBL] [Abstract][Full Text] [Related]
14. Proteasome-dependent degradation of the human estrogen receptor.
Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
[TBL] [Abstract][Full Text] [Related]
15. Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes.
Bulteau AL; Moreau M; Nizard C; Friguet B
Free Radic Biol Med; 2002 Jun; 32(11):1157-70. PubMed ID: 12031900
[TBL] [Abstract][Full Text] [Related]
16. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
17. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
[TBL] [Abstract][Full Text] [Related]
19. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma.
Adachi S; Okuno M; Matsushima-Nishiwaki R; Takano Y; Kojima S; Friedman SL; Moriwaki H; Okano Y
Hepatology; 2002 Feb; 35(2):332-40. PubMed ID: 11826406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
